Hosted on MSN
Getting the dose right in reprogramming cells
EPFL researchers have uncovered how transcription factor dosage reshapes cell identity, showing that even small differences in dose can steer cells toward completely different fates. Their findings ...
Legg-Calvé-Perthes disease is one of the most perplexing conditions in paediatric orthopaedics. It strikes children by ...
Meibomian gland carcinoma is one of the rarest and most treacherous malignancies in ocular oncology, and for decades it has ...
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...
We know our own age. 20, 30, 60 years old. But what if cells also had an age? And what if that age could not only be measured ...
In a breakthrough for longevity science, a reverse-aging treatment has been injected into a human. The technique is a sought-after solution for improving longevity by reprogramming cells. Competitors ...
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance.
A new paper in the journal Nature reveals an astonishing—and frankly unsettling—feature of some cancer cells: the ability to physically inject mitochondria into their neighboring cells. These ...
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results